Cancers (Jan 2023)

Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. <i>Cancers</i> 2022, <i>14</i>, 5344

  • Haosheng Zheng,
  • Guojie Long,
  • Yuzhen Zheng,
  • Xingping Yang,
  • Weijie Cai,
  • Shiyun He,
  • Xianyu Qin,
  • Hongying Liao

DOI
https://doi.org/10.3390/cancers15030586
Journal volume & issue
Vol. 15, no. 3
p. 586

Abstract

Read online

The authors wish to make the following corrections to this paper [...]

Keywords